Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhalable imatinib formulations, manufacture, and uses thereof

Inhalable imatinib formulations, manufacture, and uses thereof

US Patent 11229650 · Granted Jan 25, 2022

Estimated economic value: $6,611,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating rheumatic diseases using trimetazidine-based compounds2025
Compositions and methods for increasing efficiency of cardiac metabolism2025
Compositions and methods for increasing efficiency of cardiac metabolism2023
Inhalable imatinib formulations, manufacture, and uses thereof2023
Inhalable imatinib formulations, manufacture, and uses thereof2023
Inhalable imatinib formulations, manufacture, and uses thereof2023
Inhalable imatinib formulations, manufacture, and uses thereof2023
Inhalable imatinib formulations, manufacture, and uses thereof2023
Compositions that preferentially potentiate subtypes of GABAA receptors and meth2023
N-acylethanolamide derivatives and uses thereof2023
Inhalable imatinib formulations, manufacture, and uses thereof2022
Inhalable imatinib formulations, manufacture, and uses thereof2022